Clinical Trial Update: A Multicenter Open-label Phase II Study of Cemiplimab Plus Chemotherapy, Selected on the Basis of Baseline Cytidine Deaminase Activity, in Advanced Squamous Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A multicenter, open-label Phase II study is evaluating cemiplimab plus chemotherapy in advanced squamous non-small cell lung cancer, selected by baseline cytidi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cemiplimab (cemiplimab)
• Chemotherapy (chemotherapy)

Snippet

Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica | Conditions: Advanced Squamous Non-Small Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING